Monday, April 21, 2025 | 02:00 AM ISTहिंदी में पढें
Business Standard
Notification Icon
userprofile IconSearch

Drugmaker Pfizer not yet ready to release Covid-19 vaccine data

Pfizer said in a presentation that the independent monitor which will determine whether or not the trial has been successful has not conducted any interim efficacy analyses yet

Pfizer, drug manufacturer
Premium

Chief Executive Albert Bourla has previously said the company could release data on whether or not the vaccine works as early as this month

Reuters
Drugmaker Pfizer Inc said on Tuesday it was not yet ready to release data from the late-stage trial of the Covid-19 vaccine it is developing with Germany's BioNTech SE.
 
Pfizer said in a presentation that the independent monitor which will determine whether or not the trial has been successful has not conducted any interim efficacy analyses yet.
 
Chief Executive Albert Bourla has previously said the company could release data on whether or not the vaccine works as early as this month.
 
Pfizer shares fell 1% to $37.49.
 
US President Donald Trump had said a vaccine could be available before the

What you get on BS Premium?

  • Unlock 30+ premium stories daily hand-picked by our editors, across devices on browser and app.
  • Pick your favourite companies, get a daily email with all news updates on them.
  • Full access to our intuitive epaper - clip, save, share articles from any device; newspaper archives from 2006.
  • Preferential invites to Business Standard events.
  • Curated newsletters on markets, personal finance, policy & politics, start-ups, technology, and more.
VIEW ALL FAQs

Need More Information - write to us at assist@bsmail.in